C3orf80 is located on chromosome 3 at position 160,225,422 to 160,228,213 bp (spanning 2,792 bases) on the plus strand. Notably, the gene contains only one exon, which is unusual compared to most human genes that typically contain multiple exons . This single-exon structure has implications for both its expression regulation and evolutionary history. When designing experiments to study C3orf80, researchers should consider this unusual genomic organization, particularly when developing primers for amplification or when planning gene editing approaches.
The genomic neighborhood of C3orf80 includes several genes that may provide contextual clues for functional studies:
| Gene | Orientation | Location | Function |
|---|---|---|---|
| IFT80 | Minus strand | 160,256,986-160,399,880 | Part of IFT complex B |
| BRD7P2 | Plus strand | 160,100,691-160,102,912 | Pseudogene of BRD7 |
| SMC4 | Plus strand | 160,399,274-160,434,954 | Part of the condensin complex |
Researchers should consider potential functional relationships or co-expression patterns with these neighboring genes, particularly IFT80 which functions in intraflagellar transport . This genomic proximity could suggest involvement in similar biological processes, especially considering the localization of C3orf80 in cilia structures.
C3orf80 protein consists of 247 amino acids with a molecular weight of approximately 25.6 kDa before post-translational modifications. The protein has been experimentally confirmed to exist at the protein level, though its tertiary structure remains undetermined . Key structural features include:
A signal peptide at the N-terminus
A single transmembrane region
Disordered regions
Glycosylation sites
Domain of unknown function 4719 (DUF4719)
For experimental design, researchers should consider the membrane-associated nature of this protein when planning isolation, purification, and functional studies. Standard detergent-based methods for membrane protein solubilization would be appropriate starting points.
C3orf80 shows highest expression in the cerebral cortex, esophagus, and colon . This tissue-specific expression pattern suggests potential roles in neural function and digestive tract biology. When designing experiments to study C3orf80, researchers should consider using cell lines or primary cells derived from these tissues to maximize detection sensitivity. The pronounced expression in cerebral cortex indicates potential neurological functions that warrant investigation, particularly in the context of neurological disorders.
When studying C3orf80 expression via qPCR, researchers should adhere to the MIQE guidelines (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) to ensure reproducibility . Key methodological considerations include:
Sample acquisition and handling: Preserve RNA integrity by rapid processing and storage
RNA extraction: Use methods optimized for the specific tissue type being studied
RNA quality assessment: Verify RNA integrity number (RIN) > 7 before proceeding
cDNA synthesis: Select reverse transcriptase enzymes with high fidelity and consistency
Primer design: Target the single exon of C3orf80 with carefully designed primers that avoid potential SNPs
Reference gene selection: Use multiple reference genes appropriate for the tissue being studied
Biological replicates: Include sufficient biological replicates (minimum n=3) to account for natural variation
Poor RNA quality or suboptimal reaction conditions can lead to inaccurate results when studying low-abundance transcripts like C3orf80, making rigorous quality control essential throughout the experimental workflow.
Immunochemical staining has revealed that C3orf80 localizes specifically to the cilia of glandular cells in the human fallopian tube . This ciliary localization is particularly noteworthy given that one of its neighboring genes, IFT80, functions in intraflagellar transport. For studying C3orf80 localization in other cell types, researchers should consider:
Using cell lines with prominent ciliary structures (e.g., hTERT-RPE1)
Examining co-localization with established ciliary markers
Employing super-resolution microscopy techniques to precisely visualize ciliary structures
Investigating potential interactions with other ciliary proteins, particularly IFT complex components
The protein concentration in humans is relatively low at approximately 0.02 ppm, indicating that sensitive detection methods will be required for most localization studies .
Producing recombinant C3orf80 presents several challenges due to its membrane protein nature. Researchers should consider the following methodological approaches:
Expression systems: Mammalian expression systems (HEK293 or CHO cells) are recommended over bacterial systems to maintain proper post-translational modifications, particularly glycosylation
Tags and fusion partners: Include purification tags (His, FLAG) positioned to avoid interference with the transmembrane domain or signal peptide
Solubilization: Test multiple detergent conditions (DDM, CHAPS, digitonin) to identify optimal solubilization conditions
Purification strategy: Use two-step purification approaches to enhance purity
Functional validation: Confirm proper folding through binding or activity assays once established
For structural studies, researchers might consider nanobody stabilization approaches which have proven successful for other membrane proteins with similar characteristics.
The domain of unknown function 4719 (DUF4719) presents an intriguing target for functional characterization. Consider these methodological approaches:
Structure prediction: Utilize AlphaFold2 or similar advanced protein structure prediction algorithms to generate structural models
Domain truncation: Create constructs with systematic truncations or mutations within the DUF4719 domain
Interactome analysis: Employ BioID or APEX2 proximity labeling to identify interaction partners of the domain
Cross-species complementation: Test functional conservation by expressing C3orf80 from different species in knockout models
Domain-swapping experiments: Replace DUF4719 with similar domains from other proteins to assess functional specificity
The relatively high conservation of this domain across vertebrates suggests functional importance, making comparative approaches particularly valuable.
C3orf80 shows a clear pattern of evolutionary conservation across vertebrates, with orthologs dating back approximately 462 million years to cartilaginous fish . The following table illustrates the conservation patterns:
| Scientific Name | Common Name | Group | Date of Divergence (mya) | Sequence Identity | Sequence Similarity |
|---|---|---|---|---|---|
| Homo sapiens | Human | Mammalia | 0 | 100% | 100% |
| Mus musculus | House mouse | Mammalia | 87 | 92% | 94% |
| Antechinus flavipes | Yellow-footed antechinus | Marsupialia | 160 | 59% | 65% |
| Alligator mississippiensis | American alligator | Reptilia | 319 | 54% | 58% |
| Gallus gallus | Red junglefowl | Aves | 319 | 26% | 31% |
| Bufo bufo | Common toad | Amphibia | 352 | 46% | 53% |
| Latimeria chalumnae | West Indian Ocean coelacanth | Sarcopterygii | 415 | 39% | 44% |
| Danio rerio | Zebrafish | Actinopterygii | 429 | 31% | 39% |
| Callorhinchus milii | Australian ghostshark | Chondrichthyes | 462 | 29% | 35% |
The high conservation among mammals (92% identity between human and mouse) suggests important functional constraints. When designing animal models for C3orf80 research, mouse models would likely maintain functional relevance, while more distantly related models might require careful validation .
Avian orthologs of C3orf80 show remarkably low sequence identity (20-27%) compared to other vertebrate groups at similar evolutionary distances . This unusual divergence pattern may indicate:
Relaxed selective constraints in birds
Acquisition of bird-specific functions
Compensatory changes due to avian-specific physiological adaptations
Possible gene duplication events in the avian lineage
When using comparative genomics approaches to study C3orf80, researchers should account for this avian divergence by:
Analyzing avian sequences separately from other vertebrates
Investigating potential functional divergence through targeted experiments
Examining expression patterns in avian tissues compared to mammals
Considering bird-specific anatomical differences, particularly in ciliated structures
Higher expression of C3orf80 has been observed in multiple sclerosis brain lesions, suggesting potential involvement in neuroinflammatory processes . When designing experiments to investigate this association, researchers should consider:
Cell models: Using microglia or astrocyte cultures to examine C3orf80 expression under inflammatory conditions
Human samples: Analyzing C3orf80 expression in cerebrospinal fluid or brain tissue from MS patients versus controls
Functional assays: Examining effects of C3orf80 overexpression or knockdown on neuroinflammatory markers
Pathway analysis: Investigating interactions with established MS risk genes or inflammatory pathways
The predominant expression of C3orf80 in the cerebral cortex further supports potential neurological functions that warrant detailed investigation.
C3orf80 expression changes have been associated with several cancer types through various mechanistic relationships:
Low-grade glioma: Two-fold increase in expression associated with CMTM3 expression status
Esophageal squamous cell carcinoma: 107.61-fold increase in expression following CLIC1 inhibition
Invasive carcinoma: One of three genes identified in a machine learning model for predicting invasiveness
Chemotherapy response: Part of a 34-gene signature predictive of response to FOLFIRI chemotherapy
When designing cancer-related studies with C3orf80, researchers should:
Stratify samples based on molecular subtypes of the cancer being studied
Correlate C3orf80 expression with clinical outcomes and treatment responses
Investigate mechanistic relationships with known cancer-associated genes (CMTM3, CLIC1)
Consider C3orf80 as part of multi-gene signatures rather than in isolation
The substantial expression increase (107.61-fold) following CLIC1 inhibition in esophageal cancer suggests a potential compensatory relationship worth investigating further.
When studying C3orf80, which has a relatively low abundance (0.02 ppm in humans), implementing rigorous quality control measures becomes essential:
Antibody validation: Thoroughly validate antibodies using knockout/knockdown controls and multiple detection methods
Expression verification: Confirm expression levels through multiple methodologies (qPCR, western blot, immunofluorescence)
Subcellular fractionation: Enrich membrane and ciliary fractions to concentrate the protein
Signal amplification: Consider using proximity ligation assays or similar techniques for detecting low-abundance proteins
Statistical power: Calculate appropriate sample sizes to detect small changes in expression
Technical replicates: Include sufficient technical replicates to confirm experimental accuracy
The MIQE guidelines provide a framework for ensuring reproducibility in gene expression studies that is particularly relevant for low-abundance targets like C3orf80 .
Biological variability presents significant challenges when studying genes with tissue-specific expression like C3orf80. To address this:
Include sufficient biological replicates (minimum n=3, preferably n≥5) to capture natural variation
Account for demographic factors (age, sex, ethnicity) that may influence expression
Consider tissue heterogeneity, particularly in complex tissues like brain
Use appropriate statistical approaches that account for non-normal distributions
As noted by experts in gene expression analysis, "analyzing one sample once can indicate a certain process is occurring but doesn't show trends or validate that process for that sample type. Running sufficient replicates to get statistically correct information verifies an observed change in expression levels."